Challenges include vaccine mismatches resulting from the virus’ rapid evolution and resistance to antiviral drugs, and prevention is complicated by vaccine hesitancy and other factors.
It is essential to keep abreast of guidelines, resistance patterns, and diagnostic tools as well as to evaluate the literature and make recommendations on agent selection, dosing, and duration.